Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
Bora Yüksel, Ömer Karti, Tuncay Kusbeci Department of Ophthalmology, Bozyaka Training and Research Hospital, İzmir, Turkey Abstract: Since its first description, the prevention of pseudophakic cystoid macular edema (PCME) continues to pose challenges for ophthalmologists. Recent...
Guardado en:
Autores principales: | Yüksel B, Kartı Ö, Kusbeci T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5cb5fae89844692aad580d33487eb70 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis AK, et al.
Publicado: (2020) -
Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
por: Singh RP, et al.
Publicado: (2017) -
Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, vs a control group, preoperatively and postoperatively
por: Stock RA, et al.
Publicado: (2018) -
Prevention of macular oedema after cataract surgery in patients with diabetes mellitus
por: Irina A. Bashina, et al.
Publicado: (2017) -
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski A, et al.
Publicado: (2016)